VANOXERINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C28H32F2N2O
Molecular Weight	450.5633
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of VANOXERINE

Structure Search

SMILES

FC1=CC=C(C=C1)C(OCCN2CCN(CCCC3=CC=CC=C3)CC2)C4=CC=C(F)C=C4

InChI

InChIKey=NAUWTFJOPJWYOT-UHFFFAOYSA-N

InChI=1S/C28H32F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-15,28H,4,7,16-22H2

HIDE SMILES / InChI

Molecular Formula	C28H32F2N2O
Molecular Weight	450.5633
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:45:49 UTC 2023` Edited by `admin` on `Fri Dec 15 15:45:49 UTC 2023`
Record UNII	90X28IKH43
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VANOXERINE

Official Name

English

GBR 12909

Code

English

1-(2-(BIS(P-FLUOROPHENYL)METHOXY)ETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE

Common Name

English

vanoxerine [INN]

Common Name

English

GBR-12909

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C66884

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

Code System Code Type Description

DRUG BANK

DB03701

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

FDA UNII

90X28IKH43

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

NCI_THESAURUS

C81084

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

PUBCHEM

3455

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

INN

6307

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

CAS

67469-69-6

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

MESH

C043425

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

EPA CompTox

DTXSID8045143

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

CHEBI

64089

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

ChEMBL

CHEMBL281594

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

EVMPD

SUB00023MIG

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

WIKIPEDIA

VANOXERINE

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

SMS_ID

100000079072

Created by admin on Fri Dec 15 15:45:49 UTC 2023 , Edited by admin on Fri Dec 15 15:45:49 UTC 2023

PRIMARY

Related Record Type Details


					HN86OLH1NW

SODIUM-DEPENDENT NORADRENALINE TRANSPORTER

TARGET -> INHIBITOR

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					SEV29N8JND

POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY H MEMBER 2

TARGET -> INHIBITOR

Comments:

Potent blocker of cardiac hERG, Na and Ca channels; (2) block is strongly frequency-dependent especially for Na and Ca channels;has characteristics of a potentially effective and safe antiarrhythmic.

Qualification:

IC50

Amount:


					L0423Z5LDW

CYTOCHROME P450 2C8

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR

Amount:


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR

Amount:


					03BYF220B6

CYTOCHROME P450 2E1

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR

Amount:


					MWO1IP03EV

VANOXERINE HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					F202H3PMO2

SODIUM-DEPENDENT DOPAMINE TRANSPORTER

TARGET -> INHIBITOR

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:

Related Record Type Details


					90X28IKH43

ACTIVE MOIETY

Amount: